Steris Sitagliptin 50+ Metformin 500

Description

Steris Sitagliptin 50+ Metformin 500 Sitagliptin and Metformin Hydrochloride Steris Sitagliptin 50+ Metformin 500 are two medications commonly used in the treatment of type 2 diabetes. They are often prescribed together in a single tablet to help manage blood sugar levels effectively. Sitagliptin is the active ingredient in medications like Januvia. It is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. Sitagliptin works by inhibiting the enzyme DPP-4, which inactivates incretin hormones like GLP-1 (glucagon-like peptide-1). Incretin hormones play a crucial role in regulating blood sugar levels by stimulating insulin release and decreasing glucagon production, both of which lower blood sugar. By inhibiting DPP-4, sitagliptin helps increase the levels of these incretin hormones, leading to improved blood glucose control, especially after meals. Sitagliptin is typically taken as an oral tablet, usually once a day. Metformin is one of the most commonly prescribed medications for type 2 diabetes. It belongs to the biguanide class of drugs. Metformin primarily works by reducing the production of glucose by the liver and increasing the sensitivity of muscle cells to insulin, allowing better glucose uptake from the bloodstream. Additionally, metformin may help with weight management and can improve lipid profiles. It is typically taken as an oral tablet and is available in immediate-release and extended-release formulations. The combination of Steris Sitagliptin 50+ Metformin 500 is often prescribed when metformin alone is insufficient to control blood sugar levels in individuals with type 2 diabetes. This combination offers complementary mechanisms of action: metformin primarily targets insulin resistance and liver glucose production, while sitagliptin enhances the effects of incretin hormones. Together, these medications can help achieve better glycemic control.